Company profile for Arrivent

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

We have established a deep, global network of biotechs and big Pharmas, providing us with access to unique and best-in-class drug candidates at various development stages, including those coming from the booming life sciences industry in China and other emerging biotech hubs. Through strategic collaborations with innovative biopharma companies, we aim to globalize medicines for patients with a broad range of diseases, with an ...
We have established a deep, global network of biotechs and big Pharmas, providing us with access to unique and best-in-class drug candidates at various development stages, including those coming from the booming life sciences industry in China and other emerging biotech hubs. Through strategic collaborations with innovative biopharma companies, we aim to globalize medicines for patients with a broad range of diseases, with an initial focus in oncology. When identifying potential candidates, our focus is on compounds that have been validated through rigorous discovery and development processes, potentially mitigating risk

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
Pennsylvania Furnace, Pennsylvania
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/11/10/3184528/0/en/ArriVent-BioPharma-Reports-Third-Quarter-2025-Financial-Results.html

GLOBENEWSWIRE
10 Nov 2025

https://www.globenewswire.com/news-release/2025/09/22/3154297/0/en/ArriVent-Appoints-Brent-S-Rice-as-Chief-Commercial-Officer.html

GLOBENEWSWIRE
22 Sep 2025

https://www.globenewswire.com/news-release/2025/09/09/3146827/0/en/Arrivent-Presents-the-Final-Analysis-of-Firmonertinib-Monotherapy-Data-from-Global-Phase-1b-Study-in-EGFR-PACC-Mutant-Non-Small-Cell-Lung-Cancer-at-the-2025-World-Conference-on-Lun.html

GLOBENEWSWIRE
09 Sep 2025

https://www.globenewswire.com/news-release/2025/08/11/3130840/0/en/ArriVent-BioPharma-Reports-Second-Quarter-2025-Financial-Results.html

GLOBENEWSWIRE
11 Aug 2025

https://www.globenewswire.com/news-release/2025/07/21/3118677/0/en/ArriVent-s-Topline-Pivotal-Phase-3-FURVENT-Data-for-Firmonertinib-in-First-Line-NSCLC-EGFR-Exon20-Insertion-Mutations-is-Projected-to-be-Early-2026.html

GLOBENEWSWIRE
21 Jul 2025

https://www.globenewswire.com/news-release/2025/07/02/3108879/0/en/ArriVent-Announces-Pricing-of-75-Million-Public-Offering-of-Common-Stock-and-Pre-Funded-Warrants.html

GLOBENEWSWIRE
01 Jul 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty